2023 SAPA-China Annual Conference
We are excited to announce our Chief Executive Officer and founder, Chen Nan, will present at the forthcoming 2023 SAPA-China Annual Conference in Suzhou, from November 3-4, 2023. During the conference, Nan will provide detailed insights into Application of chemical proteomics techniques in covalent drug discovery. Join us on November 4th Beijing Time, for an in-depth discussion of our strategy for the drug discovery.
The Sino-American Pharmaceutical Professionals Association (SAPA) was established in 1993 and is headquartered in the center of the pharmaceutical corridor in New Jersey, USA. SAPA has built a bridge for the international exchanges in the biomedical and health industry, and has done a lot of work to promote the technical exchanges and business cooperation among multinational enterprises, Chinese local enterprises and international innovation and entrepreneurship.
For more information about the SAPA, please visit : www.sapaweb.org.
About ChomiX:
ChomiX Biotech Co., Ltd. is a leading biotechnology company focusing on the preclinical development of innovative small molecule drugs. With chemoproteomics as the core technology, ChomiX is engaged in the discovery of novel lead compounds and protein targets in living cells. Officially operated in 2021, ChomiX has established multiple intersecting platforms, including chemical biology, bioinformatics, medicinal chemistry, molecular and cell biology, etc. Now ChomiX has been authorized numbers of chemoproteomics related patents and built a laboratory with a variety of advanced instruments. ChomiX has partnered with many innovative small molecule drug R&D companies, including PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725), and hundreds of research institutes. ChomiX is committed to quickly breaking through the barriers of undruggable targets and accelerating the discovery of innovative small molecule drugs.
Post time: Oct-26-2023